MAGN vs PG
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
MAGN exhibits severe financial distress as evidenced by a weak Piotroski F-Score of 2/9, indicating a deteriorating fundamental position. While the stock appears deeply undervalued on a Price-to-Book (0.34) and Price-to-Sales (0.11) basis, these metrics are offset by negative ROE (-12.41%) and a catastrophic 5-year price decline of 94.5%. The company's earnings track record is abysmal, with zero beats in the last four quarters and massive negative surprises. Despite a healthy current ratio, the high debt-to-equity ratio and consistent operational misses suggest a value trap rather than a recovery play.
PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.
Compare Another Pair
Related Comparisons
MAGN vs PG: Head-to-Head Comparison
This page compares Magnera Corporation (MAGN) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.